Join global research on Alzheimer’s disease!

Your participation and support can help us find ways to diagnose, treat and prevent inherited and other forms of Alzheimer’s disease.

Join the Registry

DIAN Expanded Registry

Our global registry allows families to learn about research and educational opportunities and helps scientists find out how to get involved in research.
Clinical Trials

Drug trials are available for individuals who have or are at risk for dominantly inherited Alzheimer's disease.
DIAN Target Validation Symposium

This one-and-a-half-day symposium is a scientific gathering for academia, research, medical, regular and industry professionals and will be held May 25-26, 2023 in Washington, D.C., following the Alzheimer’s Association Research Roundtable. This symposium is invite only and not open to the public.

What is Dominantly Inherited Alzheimer's?

DIAD is a rare form of Alzheimer’s disease (AD) that causes memory loss and dementia in people typically in their 30s to 50s. The disease affects less than 1% of the total population.

Hearts and minds seek Alzheimer's solutions

Meet the families and researchers who are partnering to conduct groundbreaking research to find effective therapies for Alzheimer’s.

News

Mar 20, 2023

Seeking Alzheimer’s clues from few who escape genetic fate

AP News - March 16, 2023

Mar 15, 2023

Lifetime Achievement Award

Clinical Trials on Alzheimer's Disease (CTAD) - March14, 2023

Feb 3, 2023

Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers

The Source, Washington University in St. Louis - Feb 3, 2023

More News